Clinical Trial Update: A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients [Phase 2]

View source ↗

Summary

A Phase I/II trial evaluated nintedanib in Asian patients with hepatocellular carcinoma; results from the Phase II portion were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED | Results posted: 2015-08-27